Leukemia Research
Volume 26, Issue 10 , Pages 919-926 , October 2002

Phosphomonoester concentrations differ between chronic lymphocytic leukemia cells and normal human lymphocytes

  • Suzanne E Franks

      Affiliations

    • NMR and Medical Spectroscopy, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, PA 19111, USA
    • ,
  • Mitchell R Smith

      Affiliations

    • Medical Oncology, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, PA 19111, USA
    • ,
  • Fernando Arias-Mendoza

      Affiliations

    • NMR and Medical Spectroscopy, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, PA 19111, USA
    • Corresponding Author InformationCorresponding author. Present address: Hatch Center for NMR Research, Neurological Institute Basement, 710 W 168th Street, Box 48, New York, NY 10032, USA. Tel.: +1-212-305-1169; fax: +1-212-342-5773
    • ,
  • Calvin Shaller

      Affiliations

    • NMR and Medical Spectroscopy, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, PA 19111, USA
    • ,
  • Kristen Padavic-Shaller

      Affiliations

    • NMR and Medical Spectroscopy, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, PA 19111, USA
    • ,
  • Francis Kappler

      Affiliations

    • NMR and Medical Spectroscopy, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, PA 19111, USA
    • ,
  • Yun Zhang

      Affiliations

    • NMR and Medical Spectroscopy, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, PA 19111, USA
    • ,
  • William G Negendank

      Affiliations

    • NMR and Medical Spectroscopy, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, PA 19111, USA
    • Deceased, whose vision continues to inspire us and to whom this paper is dedicated.
    • ,
  • Truman R Brown

      Affiliations

    • NMR and Medical Spectroscopy, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, PA 19111, USA

Received 9 February 2001 ,Accepted 4 February 2002.

References 

  1. Negendank W. Studies of human tumors by MRS: a review. NMR Biomed. 1992;5(5):303–324
  2. Lyng H, Olsen DR, Petersen SB, Rofstad EK. 31P NMR spectroscopy studies of phospholipid metabolism in human melanoma xenograft lines differing in rate of tumour cell proliferation. NMR Biomed. 1995;8(2):65–71
  3. Radda GK, Dixon RM, Wood CA. NMR. studies of phospholipid metabolism and cell proliferation. Biochem. Soc. Trans. 1991;19(4):995–996
  4. Bogin L, Papa MZ, Polak-Charcon S, Degani H. TNF-induced modulations of phospholipid metabolism in human breast cancer cells. Biochim. Biophys. Acta. 1998;1392(2/3):217–232
  5. Freyer JP, Schor PL, Jarrett KA, Neeman M, Sillerud LO. Cellular energetics measured by phosphorous nuclear magnetic resonance spectroscopy are not correlated with chronic nutrient deficiency in multicellular tumor spheroids. Cancer Res. 1991;51(15):3831–3837
  6. Ng TC, Vijayakumar S, Majors AW, Thomas FJ, Meaney TF, Baldwin NJ. Response of a non-Hodgkin lymphoma to 60Co therapy monitored by 31P MRS in situ. Int. J. Radiat. Oncol. Biol. Phys. 1987;13(10):1545–1551
  7. Sijens PE, Baldwin NJ, Ng TC. 31P magnetic resonance spectroscopy detection of response-predictive adenosine triphosphate decrease in irradiated radiation-induced fibrosarcoma-1 tumors. Invest Radiol. 1997;32(1):39–43
  8. Steen RG. Characterization of tumor hypoxia by 31P MR spectroscopy. AJR Am J Roentgenol. 1991;157(2):243–248
  9. Adebodun F, Post JF. 31P NMR characterization of cellular metabolism during dexamethasone induced apoptosis in human leukemic cell lines. J. Cell Physiol. 1994;158(1):180–186
  10. Aiken NR, Gillies RJ. Phosphomonoester metabolism as a function of cell proliferative status and exogenous precursors. Anticancer Res. 1996;16(3B):1393–1397
  11. Bell JD, Bhakoo KK. Metabolic changes underlying 31P MR spectral alterations in human hepatic tumours. NMR Biomed. 1998;11(7):354–359
  12. Cohen JD, Robins HI. Hyperthermic enhancement of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) cytotoxicity in human leukemia cells in vitro. Cancer Res. 1987;47(16):4335–4337
  13. Cook HW, Byers DM, Palmer FB, Spence MW. Alterations of phospholipid metabolism by phorbol esters and fatty acids occur by different intracellular mechanisms in cultured glioma, neuroblastoma, and hybrid cells. J. Biol. Chem. 1989;264(5):2746–2752
  14. Evelhoch JL, Gillies RJ, Karczmar GS, et al.  Applications of magnetic resonance in model systems: cancer therapeutics. Neoplasia. 2000;2(1-2):152–165
  15. Furman E, Margalit R, Bendel P, Horowitz A, Degani H. In vivo studies by magnetic resonance imaging and spectroscopy of the response to tamoxifen of MCF7 human breast cancer implanted in nude mice. Cancer Commun. 1991;3(9):287–297
  16. Gillies RJ, Bhujwalla ZM, Evelhoch J, et al.  Applications of magnetic resonance in model systems: tumor biology and physiology. Neoplasia. 2000;2(1-2):139–151
  17. He Z, Evelhoch JL, Mohammad RM, et al.  Magnetic resonance imaging to measure therapeutic response using an orthotopic model of human pancreatic cancer. Pancreas. 2000;21(1):69–76
  18. Kang H, Ballinger JR, Sweeney C, Croker BP, Scott KN. 31P changes as a measure of therapy response in human osteosarcomas implanted into nude mice. Magn Reson Imaging. 1994;12(6):935–943
  19. Kara J, Zimakova NI, Serebryakova EA, Dedkova V, Zolotaryov AE. Pharmacokinetics and metabolism of a new antitumor semisynthetic ether phospholipid, 14C-labeled plasmanyl-(N-acyl)ethanolamine, in mice bearing sarcoma Mc11. J. Cancer Res. Clin. Oncol. 1994;120(11):662–667
  20. Kiss Z, Crilly KS, Anderson WH. Carcinogens stimulate phosphorylation of ethanolamine derived from increased hydrolysis of phosphatidylethanolamine in C3H/101/2 fibroblasts. FEBS Lett. 1993;336(1):115–118
  21. Matsumoto T, Kawanobe Y, Morita K, Ogata E. Effect of 1,25-dihydroxyvitamin D3 on phospholipid metabolism in a clonal osteoblast-like rat osteogenic sarcoma cell line. J. Biol. Chem. 1985;260(25):13704–13709
  22. Ronen SM, DiStefano F, McCoy CL, et al.  Magnetic resonance detects metabolic changes associated with chemotherapy-induced apoptosis. Br J Cancer. 1999;80(7):1035–1041
  23. Ruiz-Cabello J, Cohen JS. Phospholipid metabolites as indicators of cancer cell function. NMR Biomed. 1992;5(5):226–233
  24. Sijens PE, Baldwin NJ, Ng TC. Multinuclear MR investigation of the metabolic response of the murine RIF-1 tumor to 5-fluorouracil chemotherapy. Magn Reson Med. 1991;19(2):373–385
  25. Sorensen AM, Baran DT. 1 alpha, 25-Dihydroxyvitamin D3 rapidly alters phospholipid metabolism in the nuclear envelope of osteoblasts. J Cell Biochem. 1995;58(1):15–21
  26. Sterin M, Cohen JS, Mardor Y, Berman E, Ringel I. Levels of phospholipid metabolites in breast cancer cells treated with antimitotic drugs: a 31P-magnetic resonance spectroscopy study. Cancer Res. 2001;61(20):7536–7543
  27. Sun SH, Ou HC, Jang TH, Lin LB, Huang HM. Altered phospholipid metabolism in sodium butyrate-induced differentiation of C6 glioma cells. Lipids. 1997;32(3):273–282
  28. Tausch-Treml R, Kopf-Maier P, Baumgart F, et al.  31P nuclear magnetic resonance spectroscopy, histology and cytokinetics of a xenografted hypopharynx carcinoma following treatment with cisplatin: comparison in three sublines with increasing resistance. Br J Cancer. 1991;64(3):485–493
  29. Cohen JS. Differences in phosphate metabolite levels, 1987.
  30. Adebodun F. Phospholipid metabolism and resistance to glucocorticoid-induced apoptosis in a human leukemic cell line: a 31P-NMR study using a phosphonium analog of choline. Cancer Lett. 1999;140(1/2):189–194
  31. Horowitz AF. Manipulation of the lipid composition of cultured animal cells. In: Nicolson GL, editor. Dynamic Aspects of Cell Surface Organization. New York: North-Holland 1977, pp. 295–305.
  32. Kuesel AC, Graschew G, Hull WE, Lorenz W, Thielmann HW. 31P NMR studies of cultured human tumor cells Influence of pH on phospholipid metabolite levels and the detection of cytidine 5′-diphosphate choline. NMR Biomed. 1990;3(2):78–89
  33. Negendank W, Li CW, Padavic-Shaller K, Murphy-Boesch J, Brown TR. Phospholipid metabolites in 1H-decoupled 31P MRS in vivo in human cancer: implications for experimental models and clinical studies. Anticancer Res. 1996;16(3B):1539–1544
  34. Negendank WG, Padavic-Shaller KA, Li CW, et al.  Metabolic characterization of human non-Hodgkin’s lymphomas in vivo with the use of proton-decoupled phosphorus magnetic resonance spectroscopy. Cancer Res. 1995;55(15):3286–3294
  35. Jaffe ES. Histopathology and immunopathology. In: Magrath IT, editor. The Non-Hodgkin’s lymphomas, 2nd ed, New York: Oxford University Press, 1997, p. 79–108.
  36. Hirata F, Toyoshima S, Axelrod J, Waxdal MJ. Phospholipid methylation: a biochemical signal modulating lymphocyte mitogenesis. Proc. Natl. Acad. Sci. USA. 1980;77(2):862–865
  37. Niwa Y, Taniguchi S. Phospholipid base exchange in human leukocyte membranes: quantitation and correlation with other phospholipid biosynthetic pathways. Arch Biochem. Biophys. 1986;250(2):345–357
  38. Kiss Z, Tomono M, Anderson WB. Phorbol ester selectively stimulates the phospholipase D-mediated hydrolysis of phosphatidylethanolamine in multidrug-resistant MCF-7 human breast carcinoma cells. Biochem. J. 1994;302(Pt 3):649–654
  39. Gillham H, Brindle KM. 31P NMR measurements of the effects of unsaturated fatty acids on cellular phospholipid metabolism. Magn. Reson. Med. 1996;35(4):481–488
  40. Dixon RM, Tian M. Phospholipid synthesis in the lymphomatous mouse liver studied by 31P nuclear magnetic resonance spectroscopy in vitro and by administration of 14C-radiolabelled compounds in vivo. Biochim. Biophys. Acta. 1993;1181(2):111–121
  41. Thomas CP, Dixon RM, Tian M, et al.  Phosphorus metabolism during growth of lymphoma in mouse liver: a comparison of 31P magnetic resonance spectroscopy in vivo and in vitro. Br J Cancer. 1994;69(4):633–640
  42. Sharma RK, Jain V. Radiotherapeutic response of Ehrlich ascites tumor cells perfused in agarose gel threads. Strahlenther Onkol. 2001;177(4):212–219
  43. Dahiya R, Boyle B, Park HD, Kurhanewicz J, Macdonald JM, Narayan P. 13-CIS-Retinoic acid-mediated growth inhibition of DU-145 human prostate cancer cells. Biochem Mol Biol Int. 1994;32(1):1–12
  44. Kalra R, Wade KE, Hands L. Phosphomonoester is associated with proliferation in human breast cancer: a 31P MRS study. Br J Cancer. 1993;67(5):1145–1153
  45. Dixon RM, Angus PW, Rajagopalan B, Radda GK. Abnormal phosphomonoester signals in 31P MR spectra from patients with hepatic lymphoma. A possible marker of liver infiltration and response to chemotherapy. Br J Cancer. 1991;63(6):953–958
  46. Glazer GM, Smith SR, Chenevert TL, Martin PA, Stevens AN, Edwards RH. Image localized 31P magnetic resonance spectroscopy of the human liver. NMR Biomed. 1989;1(4):184–189
  47. Shedd SF, Lutz NW, Hull WE. The influence of medium formulation on phosphomonoester and UDP-hexose levels in cultured human colon tumor cells as observed by 31P NMR spectroscopy. NMR Biomed. 1993;6(4):254–263
  48. Podo F. Tumour phospholipid metabolism. NMR Biomed. 1999;12(7):413–439
  49. Aboagye EO, Bhujwalla ZM. Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Res. 1999;59(1):80–84
  50. Dixon RM. NMR studies of phospholipid metabolism in hepatic lymphoma. NMR Biomed. 1998;11(7):370–379
  51. Ting YL, Sherr D, Degani H. Variations in energy and phospholipid metabolism in normal and cancer human mammary epithelial cells. Anticancer Res. 1996;16(3B):1381–1388
  52. Dagnelie PC, Bell JD, Williams SC, Bates TE, Abel PD, Foster CS. Altered phosphorylation status, phospholipid metabolism and gluconeogenesis in the host liver of rats with prostate cancer: a 31P magnetic resonance spectroscopy study. Br J Cancer. 1993;67(6):1303–1309
  53. Smith TA, Glaholm J, Leach MO. A comparison of in vivo and in vitro 31P NMR spectra from human breast tumours: variations in phospholipid metabolism. Br J Cancer. 1991;63(4):514–516
  54. Daly PF, Lyon RC, Faustino PJ, Cohen JS. Phospholipid metabolism in cancer cells monitored by 31P NMR spectroscopy. J. Biol. Chem. 1987;262(31):14875–14878
  55. Lloveras J, Hamza M, Chap H, Douste-Blazy L. Action of hemicholinium-3 on phospholipid metabolism in Krebs II ascites cells. Biochem. Pharmacol. 1985;34(22):3987–3993

PII: S0145-2126(02)00035-8

Leukemia Research
Volume 26, Issue 10 , Pages 919-926 , October 2002

Article Tools

* Image Usage & Resolution